Sprint Bioscience AB (SPRINT) — Cash Flow Reinvestment Rate
Sprint Bioscience AB (SPRINT) has a Cash Flow Reinvestment Rate of 0.00x as of December 2025, reinvesting Skr105.00K (capex Skr65.00K plus investments Skr40.00K) from operating cash flow of Skr115.84 Million. Check how high is Sprint Bioscience AB's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Sprint Bioscience AB Cash Flow Reinvestment Rate (2015–2025)
Historical reinvestment intensity for Sprint Bioscience AB across 4 annual periods. Explore Sprint Bioscience AB cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Sprint Bioscience AB (2015–2025)
Year-by-year capital reinvestment analysis for Sprint Bioscience AB. For live market cap and broader valuation context, see Sprint Bioscience AB market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.00x | Skr134.00K | Skr83.53 Million | Skr94.00K | ▼ -99.3% |
| 2023 | 0.21x | Skr4.91 Million | Skr22.87 Million | Skr2.45 Million | ▼ -91.4% |
| 2016 | 2.50x | Skr19.82 Million | Skr7.93 Million | Skr9.91 Million | ▼ -66.4% |
| 2015 | 7.43x | Skr6.19 Million | Skr833.54K | Skr6.19 Million | — |